Locate Glendale buprenorphine and suboxone doctors who specialize in the treatment of opioid addiction.
|
Dr. Marcia Olsson Mastrin, M.D.
7147 North 59th Avenue
Glendale, AZ 85301
Main Tel: (877) 435-5557
|
|
Rick Michael Wesley Sloan,
COMPASSIONATE CARE CENTERS
4494 West Peoria Avenue, Unit #115-A
Glendale, AZ 85302
Main Tel: (623) 878-5800
|
|
Dr. Lauren T. Bonner, M.D.
La Frontera/Empact
4425 W Olive Ave
Glendale, AZ 85302
Main Tel: (480) 784-1514
|
|
Dr. Martin Howard Newman, M.D.
Aurora Behavioral Health
6015 W Peoria
Glendale, AZ 85302
Main Tel: (623) 344-4400
|
|
Dr. Karnail S. Dhillon, M.D.
5601 West Eugie Avenue
Suite 104
Glendale, AZ 85304
Main Tel: (602) 548-7300
|
|
Dr. Balwinder Singh Pawar, M.D.
5601 West Eugie Avenue
Unit 104
Glendale, AZ 85304
Main Tel: (602) 548-7300
|
|
Dr. Jason E Gittman, M.D.
8914 North 94th Avenue
Suite 100
Peoria, AZ 85345
Main Tel: (623) 877-0100
|
|
LaVont L. Cooper, M.D.
2423 West Dunlap Avenue
Suite 150
Phoenix, AZ 85021
Main Tel: (602) 216-6862
|
|
Thomas Cyriac,
8836 North 23rd Avenue
Suite B-1
Phoenix, AZ 85021
Main Tel: (602) 944-9810
|
|
Dr. Varun Monga, M.D.
5555 W THUNDERBIRD RD
Glendale, AZ 85306
Main Tel: (602) 865-4793
|
|
Rami Dieb, M.D.
Banner Health- Attn: Behavioral Health
5555 West Thunderbird Road
Glendale, AZ 85306
Main Tel: (602) 865-4793
|
|
Dr. Harshdeep Babbar, M.D.
8232 West Cactus Road, Suite 124
Peoria, AZ 85381
Main Tel: (623) 876-1634
|
|
Dr. Jatinder S. Purewal, M .D.
6677 West Thunderbird Road
Suite C- 142
Glendale, AZ 85306
Main Tel: (623) 878-2100
|
Sublocade Now Available
Sublocade is a newly released medication alternative for treating opioid addiction. It is a product of Indivior, the pharmaceutical company responsible for Suboxone. Sublocade is a once monthly injection of time-released buprenorphine typically provided to patients who have been receiving buprenorphine for at least (7) days and who are stable on their medication. The injection Read More
Ohio Increases Buprenorphine Access
In 2017, Ohio increased its number of buprenorphine-approved prescribers by 266. This was the result of a $2.3 million dollar Federal grant that provided state-wide training to doctors, nurse practitioners, and physician assistants as reported by Cleveland.com. Historically, Ohio had numerous communities that were underserved with 19 counties having no buprenorphine providers at the beginning Read More
The Drug Treatment Act of 2000 permitted doctors who meet certain training qualifications to prescribe buprenorphine in the treatment of heroin addiction and other opioid addictions. Buprenorphine physicians became able to assist opioid addicted patients in an office setting bypassing the restrictions that typically apply to patients receiving methadone. This treatment method maximized patient convenience and accessibility thus increasing the number of people who could access medication-assisted treatment (MAT) for opioid addiction.
Sublocade is a newly released medication alternative for treating opioid addiction. It is a product of Indivior, the pharmaceutical company responsible for